Summary: Researchers have discovered that increased activity in the reticular thalamic nucleus might contribute to autism-like behaviors in mice. This particular area of the brain, responsible for controlling sensory information, was found to be hyperactive during both sensory stimuli and social interactions, resulting in symptoms such as seizures, repetitive actions, and reduced social engagement.
Interestingly, when this activity was suppressed using various drugs—some of which are already being tested for epilepsy—researchers observed a reversal of these symptoms. This suggests there could be overlapping mechanisms in the brain related to both autism and epilepsy, opening the door for potential new treatment avenues.
Key Facts
- Brain Target: Overactivity in the reticular thalamic nucleus associated with behaviors typical of autism.
- Treatment Success: Medications that dampened this brain activity led to a reversal of autism-like symptoms in mice.
- Shared Pathways: Results highlight potential links between autism and epilepsy, indicating new therapeutic possibilities.
Stanford researchers delving into the neurological bases of autism spectrum disorder have pinpointed hyperactivity in a specific brain region that may drive behaviors linked to the condition.
Using mouse models, the team focused on the reticular thalamic nucleus, which plays a critical role in modulating sensory input between the thalamus and cortex, identifying it as a potential target for new treatments.
They managed to reverse behaviors reminiscent of autism—like increased seizure susceptibility, heightened sensory sensitivity, and diminished social interaction—by administering drugs that reduced activity in this brain area.
Interestingly, those same drugs are currently under evaluation for epilepsy treatment, emphasizing where the neurological underpinnings of autism and epilepsy intersect, which might explain their common co-occurrence in patients.
The research findings will be published on August 20 in Science Advances. The study is led by John Huguenard, PhD, a professor of neurology, with contributions from postdoctoral scholar Sung-Soo Jang, PhD.
While connections between the thalamus and cortex have been implicated in autism in both humans and animal studies, the specific role of the reticular thalamic nucleus remained unclear until now.
The researchers recorded the brain activity in this area in mice while they were observed interacting with stimuli. In genetically modified mice that model autism, they found increased activity in the reticular thalamic nucleus when the mice were exposed to light or other sensory inputs, and during social engagement. They also noted spontaneous bursts of activity leading to seizures.
Epilepsy is notably more common among individuals with autism compared to the general populace—about 30% versus 1%—yet the reasons for this connection are not fully understood. In light of this, the team tested an investigational seizure medication, Z944, which showed potential in reversing behavioral deficits in the autism mouse model.
Additionally, using a method that genetically changes neurons to respond to specific drugs, dubbed DREADD-based neuromodulation, researchers managed to mitigate the overactivity in the reticular thalamic nucleus, consequently improving the behavior of the autism model. They also found they could induce similar behavioral changes in typical mice by enhancing activity in this brain region.
This research underlines the reticular thalamic nucleus as a promising new target for treating autism spectrum disorders.
About this autism and neuropharmacology research news
Original Research: The study identified the role of the reticular thalamic nucleus in driving behaviors associated with autism spectrum disorders using a knockout mouse model.
